Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Bancroft Charles A
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   168,937    

Indirect Shares

  300,000      
Direct Value   $6,424,696    

Indirect Value

  $12,702,000      
Total Shares   468,937      
Total Value   $19,126,696      


Bristol-Myers Squibb Co
 $5,823,190 Colgate Palmolive Co
 $516,916 Kodiak Sciences Inc.
 $84,590 Bristol-Myers Squibb Co
 $5,823,190 Colgate Palmolive Co
 $516,916 Kodiak Sciences Inc.
 $84,590
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY EVP, Head of Integration 2020-03-10 137,534 2020-03-10 300,000    Premium*  
            Colgate Palmolive Co CL Director 2018-05-14 5,455 2017-05-15 0    Premium*  
            Kodiak Sciences Inc. KOD Director 2020-04-02 25,948 0    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BMY Bristol-Myers Squibb Co Chief Financial Officer   •       –      –    2011-03-03 4 D $26.14 $23,657 D/D (905) 42,365 0 -
BMY Bristol-Myers Squibb Co Chief Financial Officer   •       –      –    2011-03-04 4 D $26.43 $19,717 D/D (746) 43,671 0 -
BMY Bristol-Myers Squibb Co Chief Financial Officer   •       –      –    2011-03-06 4 D $26.43 $13,585 D/D (514) 44,569 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-01 4 D $32.64 $146,978 D/D (4,503) 52,453 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-02 4 D $32.59 $88,514 D/D (2,716) 57,208 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-03 4 D $32.59 $29,494 D/D (905) 58,790 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-04 4 D $32.59 $24,312 D/D (746) 60,096 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-06 4 D $32.33 $149,559 D/D (4,626) 66,795 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-03-03 4 D $37.15 $28,123 D/D (757) 72,806 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-03-07 4 D $37.53 $1,179,530 D/D (31,429) 119,015 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-03 4 D $53.49 $3,285,302 D/D (61,419) 152,303 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-06 4 D $55.56 $307,580 D/D (5,536) 159,062 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-10 4 D $56.14 $235,563 D/D (4,196) 164,185 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-11-01 4 D $58.19 $81,291 D/D (1,397) 98,269 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-02 4 D $62.30 $1,624,784 D/D (26,080) 144,434 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-02 4 D $62.30 $400,776 D/D (6,433) 111,330 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-06 4 D $65.12 $414,619 D/D (6,367) 171,702 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-10 4/A D $65.53 $531,645 D/D (8,113) 160,857 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-10 4 D $65.53 $531,645 D/D (8,113) 181,609 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-11-01 4 D $65.75 $91,787 D/D (1,396) 162,561 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-06 4 D $64.71 $416,409 D/D (6,435) 170,418 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4 D $64.94 $2,365,569 D/D (36,427) 221,724 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4 D $0.00 $0 D/D (92) 193,278 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4/A D $64.94 $2,365,569 D/D (36,427) 214,895 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4/A D $0.00 $0 D/D (92) 186,449 0 -

  117  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed